Back
GT Biopharma, Inc. 10K Form
Sell
34
GTBP
GT Biopharma, Inc.
Last Price:
$0.44
Seasonality Move:
-0.12%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GTBP News And Ratings
See the #1 stock for the next 7 days that we like better than GTBP
GTBP Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.23 |
| Price / Book: | 2.62 |
Profitability
| EPS (TTM): | -14.61930 |
|---|---|
| Net Income (TTM): | $-45.7M |
| Gross Margin: | $0 |
| Return on Equity: | -1294.23% |
| Return on Assets: | -863.75% |
GT Biopharma, Inc. Earnings Forecast
Key GT Biopharma, Inc. Financial Ratios
-
Per Share Earnings over the last 42 years have been positive in 24 years.
GT Biopharma, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GTBP |
| Website: | gtbiopharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.22 |
| Quick Ratio: | 2.98 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
GTBP Technical Analysis vs Fundamental Analysis
Sell
34
GT Biopharma, Inc. (GTBP)
is a Sell
Is GT Biopharma, Inc. a Buy or a Sell?
-
GT Biopharma, Inc. stock is rated a SellThe current GT Biopharma, Inc. [GTBP] share price is $0.45. The Score for GTBP is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.